These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 7135927)
1. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine]. Kan GA; Borsuk EA; Vorob'eva MS Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927 [TBL] [Abstract][Full Text] [Related]
2. [Characteristics of neurovirulence, stability, and immunogenicity of attenuated variants of TP-21 Langat virus]. Sokolova ED; Kamalov II; Konovalov GV Vopr Virusol; 1994; 39(5):220-3. PubMed ID: 7716907 [TBL] [Abstract][Full Text] [Related]
3. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus. Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG mBio; 2019 Apr; 10(2):. PubMed ID: 31015334 [TBL] [Abstract][Full Text] [Related]
4. [Quantitative indices of the immune status of persons inoculated with different vaccines against tick-borne encephalitis]. Bukovskaia SN; Vorob'eva MS; Karpovich LG; Shalamberidze TD Vopr Virusol; 1983; 28(4):100-3. PubMed ID: 6636697 [TBL] [Abstract][Full Text] [Related]
5. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice. Pletnev AG Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of tick-borne encephalitis DNA vaccines in monkeys. Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of tick-borne encephalitis virus using large-scale random codon re-encoding. de Fabritus L; Nougairède A; Aubry F; Gould EA; de Lamballerie X PLoS Pathog; 2015 Mar; 11(3):e1004738. PubMed ID: 25734338 [TBL] [Abstract][Full Text] [Related]
8. [A live vaccine against tick-borne encephalitis: the principles of selecting the vaccinal strains]. Kamalov II; Sokolova ED; Il'enko VI; Rozhkova LV Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):70-6. PubMed ID: 8067096 [TBL] [Abstract][Full Text] [Related]
9. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus. Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085 [TBL] [Abstract][Full Text] [Related]
10. [A comparison of the protective properties of preparations of the virion and nonvirion ("soluble") antigens of the tick-borne encephalitis virus]. Liapustin VN; Pivanova GP; Karavanov AS; Lashkevich VA Vopr Virusol; 1991; 36(6):498-500. PubMed ID: 1785186 [TBL] [Abstract][Full Text] [Related]
11. [A virulence study of tick-borne encephalitis virus strains isolated in the southern Soviet Far East]. Leonova GN; Muratkina SM; Krugliak SP Vopr Virusol; 1990; 35(5):399-401. PubMed ID: 2267782 [TBL] [Abstract][Full Text] [Related]
13. Generation and Characterization of a Chimeric Tick-Borne Encephalitis Virus Attenuated Strain ChinTBEV. Wang HJ; Li XF; Qin CF Methods Mol Biol; 2016; 1403():285-93. PubMed ID: 27076137 [TBL] [Abstract][Full Text] [Related]
14. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen]. El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574 [TBL] [Abstract][Full Text] [Related]
15. [Characteristics of the response of mice with temporary immunodepression to the administration of live or inactivated vaccine against tick-borne encephalitis]. Vargin VV; Semenov BF Vopr Virusol; 1979; (1):52-7. PubMed ID: 217179 [TBL] [Abstract][Full Text] [Related]
16. [Structure of tick-borne encephalitis virus populations in foci with various levels of morbidity in the human population]. Pustovalova VIa; Katin AA Vopr Virusol; 1984; 29(3):323-6. PubMed ID: 6464426 [TBL] [Abstract][Full Text] [Related]
17. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm]. Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069 [TBL] [Abstract][Full Text] [Related]
18. [Experimental infection caused by attenuated strains of viruses of the tick-borne encephalitis complex in the bodies of immunosuppressed animals]. Ladyzhenskaia IP; Vorob'eva MS Vopr Virusol; 1977; (6):675-9. PubMed ID: 602146 [TBL] [Abstract][Full Text] [Related]
19. [Isolation of split and whole-virion tick-borne encephalitis vaccines in an experiment and the characteristics of their immunogenic and antigenic properties]. Osipova EG; Solianik RG; Fedorov IuV; Tymchishin PN Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):50-3. PubMed ID: 3687295 [TBL] [Abstract][Full Text] [Related]
20. [The degree of virulence in Far Eastern strains of the tick-borne encephalitis virus]. Muratkina SM; Leonova GN Vopr Virusol; 1992; 37(4):211-5. PubMed ID: 1281947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]